RXST vs NERV

Comparison between RxSight Inc (RXST, Company) and Minerva Neurosciences Inc (NERV, Company).

Both RXST and NERV are from the Healthcare sector.

5-Year PerformanceRXST has outperformed NERV, delivering a return of -22.1% compared to -26.6%

RXST vs NERV - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RXST(COMPANY)	NERV(COMPANY)
Market Cap	$196M	$196M
Max Drawdown	92.86%	98.86%
Sharpe Ratio	-1.07	1.06
5Y Beta	1.33	0.69
Industry	Medical Devices	Biotechnology
P/E Ratio	-4.18	-0.47
Forward P/E	116.28	11.21
PEG Ratio	-0.06	N/A
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	-11.03%	-7.59%

Market Cap

RXST

$196M

Winner

NERV

$196M

Max Drawdown

Winner

RXST

92.86%

NERV

98.86%

Sharpe Ratio

RXST

-1.07

Winner

NERV

1.06

5Y Beta

RXST

1.33

Winner

NERV

0.69

Industry

RXST

Medical Devices

NERV

Biotechnology

P/E Ratio

Winner

RXST

-4.18

NERV

-0.47

Forward P/E

RXST

116.28

Winner

NERV

11.21

PEG Ratio

RXST

-0.06

NERV

N/A

Debt to Equity

RXST

0.00%

NERV

0.00%

Free Cash Flow Yield

RXST

-11.03%

Winner

NERV

-7.59%

RXST vs NERV - Historical Returns

Returns include dividend reinvestment.

Period	RXST	NERV
1 month	-21.17%	-5.70%
3 months	-35.65%	-42.54%
6 months	-61.58%	+15.50%
1 year	-65.90%	+146.96%
5 years(CAGR)	-22.08%	-26.64%
10 years(CAGR)	N/A	-25.19%
Max(CAGR)	-22.08%	-18.05%

RXST

-21.17%

Winner

NERV

-5.70%

Winner

RXST

-35.65%

NERV

-42.54%

RXST

-61.58%

Winner

NERV

+15.50%

RXST

-65.90%

Winner

NERV

+146.96%

5Y(CAGR)

Winner

RXST

-22.08%

NERV

-26.64%

10Y(CAGR)

RXST

N/A

NERV

-25.19%

Max(CAGR)

RXST

-22.08%

Winner

NERV

-18.05%

RXST vs NERV - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

Year	RXST	NERV
2026	-54.43%	+14.03%
2025	-69.84%	+74.78%
2024	-6.19%	-63.88%
2023	+215.49%	+307.28%
2022	+11.83%	-78.39%
2021	-29.69%	-66.34%
2020	N/A	-69.37%
2019	N/A	+2.75%
2018	N/A	+8.71%
2017	N/A	-48.51%
2016	N/A	+99.83%
2015	N/A	-0.65%
2014	N/A	-0.50%

RXST vs NERV Drawdown Comparison

The maximum drawdown for RXST was -92.86%, occurring on Jun 17, 2026. This drawdown has not yet recovered.

The maximum drawdown for NERV was -98.86%, occurring on Apr 9, 2025. This drawdown has not yet recovered.

The current RXST drawdown is -92.64%. The current NERV drawdown is -96.20%.

Rank	RXST	NERV
#1	-92.86% May 15, 2024 - Jun 17, 2026	-98.86% May 26, 2020 - Apr 9, 2025
#2	-48.21% Aug 2, 2021 - Apr 13, 2023	-71.63% Sep 20, 2016 - May 21, 2020
#3	-37.34% Jul 31, 2023 - Dec 6, 2023	-53.73% Sep 10, 2014 - May 26, 2016
#4	-20.23% Feb 27, 2024 - May 2, 2024	-33.29% Jun 2, 2016 - Sep 20, 2016
#5	-13.18% Dec 27, 2023 - Jan 8, 2024	-17.13% Jul 28, 2014 - Sep 9, 2014
#6	-7.38% Jul 17, 2023 - Jul 28, 2023	-13.97% Jul 14, 2014 - Jul 28, 2014
#7	-7.07% May 26, 2023 - Jun 22, 2023	-4.07% May 26, 2016 - May 31, 2016
#8	-6.44% May 6, 2024 - May 15, 2024	-3.75% Jul 3, 2014 - Jul 10, 2014
#9	-6.22% Feb 1, 2024 - Feb 12, 2024	-1.99% May 21, 2020 - May 26, 2020
#10	-5.35% Jun 22, 2023 - Jun 29, 2023	-1.05% Jul 10, 2014 - Jul 14, 2014
#11	-5.19% Jan 29, 2024 - Feb 1, 2024	-0.83% Jul 1, 2014 - Jul 3, 2014
#12	-4.63% Dec 14, 2023 - Dec 27, 2023	N/A
#13	-3.87% May 3, 2023 - May 8, 2023	N/A
#14	-3.59% Jan 11, 2024 - Jan 22, 2024	N/A
#15	-3.39% Jun 29, 2023 - Jul 7, 2023	N/A